Brand Reinforces Commitment to Delivering Optimal Pharmacy Experience
Somerset, NJ, – January 30, 2017 – PharmScript, a leading pharmacy provider to long-term care and post-acute care facilities, today announced the unveiling of its new brand identity, including a new mission, vision, values, logo and website. Building on the company’s strong reputation, the new PharmScript brand is designed to reflect its mission of providing a seamless pharmacy experience and supporting clients in delivering patient-centered care.
“Our commitment to our clients, attention to detail, and continued innovation have been cornerstones of our company. With a refreshed brand, our outward appearance now accurately conveys this message,” said Michael Segal, chief executive officer of PharmScript. “We are proud to be a true partner to healthcare facilities by helping our clients deliver quality care, efficiently and effectively.”
“Throughout the evolution of our business, our goal has been consistent—provide a seamless pharmacy experience for clients so they can provide optimal clinical care for their residents and patients,” said Saul Greenberger, founder of PharmScript. “Today, we have a new brand that not only visually communicates this commitment, but truly aligns with our clients in providing patient-centered care.”
From PharmScript’s eight pharmacies, the organization services more than 300 facilities and thousands of residents. PharmScript serves facilities in Delaware, Connecticut, Florida, Maryland, New Jersey, New York, Pennsylvania, Texas, and Washington, D.C.
About PharmScript
As a leading pharmacy provider to long-term care and post-acute care facilities, PharmScript partners with healthcare organizations across nine states and delivers medications to thousands of residents and patients. Founded in 2009 with the goal of providing a seamless pharmacy experience, PharmScript is committed to helping providers deliver patient-centered care with high quality service, accuracy, timeliness, and cost containment. For more information, please visit www.pharmscript.com.